Ny-Eso-1 Protein Formulated With Immunostimulatory Complexes (Iscom (R) Adjuvant) In Patients With Minimal Residual Disease Induces A Broad-Based Immune Response Involving Cd4 & Cd8 T Lymphocytes And High Titered Antibody.
CLINICAL CANCER RESEARCH(2003)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要